SciSparc Successfully Completed Production of its Proprietary Drug Candidate SCI-110 for its Upcoming Clinical Trial On Tourette Syndrome
TEL AVIV, Israel, March 06, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company”…
TEL AVIV, Israel, March 06, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company”…
BOSTON, March 06, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company…
New Drug Application for VP-102 assigned PDUFA goal date of July 23, 2023 VP-102 has…
Relay Therapeutics to host conference call following AACR presentation CAMBRIDGE, Mass., March 06, 2023 (GLOBE…
To Prove Our Point, Zerify is Offering a Three Month Free Trial of it’s Zerify Meet…
FourKites and Spotos Join Forces Companies to Bring Real-time Supply Chain Visibility to European Shippers…
Figure 1 Bomboré Plan Map Overview Figure 2 P8P9 Cross Section 1350N Figure 3 P8P9…
Brooklyn, New York–(Newsfile Corp. – March 6, 2023) – Laser Love, a medical spa treatment…
Vancouver, British Columbia–(Newsfile Corp. – March 6, 2023) – Coloured Ties Capital Inc. (TSXV: TIE)…
Scope’s partnership will align Scope and Farm Flight in developing industry-leading, analytical solutions in the…
TOKYO, Mar 6, 2023 – (JCN Newswire) – TOYOTA has unveiled the all new Crown…
TORONTO, ON, Mar 6, 2023 – (ACN Newswire) – Palladium One Mining Inc. (TSXV: PDM)…
Starlight Therapeutics Inc., a Lantern subsidiary, will focus exclusively on the clinical development of therapies…
The Solar Revenue Put supports Pivot Energy in upsizing its loan facility. SAN FRANCISCO–(BUSINESS WIRE)–#solardata–kWh…
March 8 press conference “Driving Innovation Together” HOUSTON–(BUSINESS WIRE)–#DrivingInnovationTogether–JB Poindexter & Co (JBPCO) business units…
Kelsey Hightower of Google and Mahadev “Dr. Satya” Satyanarayanan (The Father of Edge Computing) are…
DETROIT–(BUSINESS WIRE)–Bankjoy, a digital banking provider, today announced a funding round led by Curql Collective,…
OTL-200 pre-BLA meeting granted for second quarter of 2023 following productive clinical Type B meeting…
Compelling clinical data with clear paths to products and multiple near‐term value-creating catalysts Complementary technology…
MELBOURNE, Australia, March 06, 2023 (GLOBE NEWSWIRE) — Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage…